NA High Content Screening Market - Industry Trends and Forecast to 2030

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $3,500	177 Pages	Data Bridge Market Research	June, 2023	DAABD18055183

Best Price Guarantee
Price	from $3,500
Length	177 Pages
Publisher	Data Bridge Market Research
Published Date	June, 2023
SKU	DAABD18055183

NA High Content Screening Market - Industry Trends and Forecast to 2030

The North America high content screening market is expected to reach USD 1,918,847.03 thousand by 2030 from USD 1,083,968.48 thousand in 2022, growing at a CAGR of 7.4% during the forecast period of 2023 to 2030.

Market Segmentation
North America High Content Screening Market, By Product Type (Instruments, Consumables, Software, Services, and Accessories), Application (Primary and Secondary Screening, Target Identification and Validation, Toxicity Studies, Compound Profiling, and Others), Technology (Microscopy, Flow Cytometry, Mass Spectrometry, Western Blotting, ELISA, Immunohistochemistry, and Others), End User (Pharmaceutical and Biotechnology Companies, Academic and Government Institutes, Contract Research Organizations, Laboratories, and Others), Distribution Channel (Direct Tenders and Retail Sales), Country (U.S., Canada, and Mexico) - Industry Trends and Forecast to 2030

Overview of North America High Content Screening Market Dynamics

Driver
• Increasing drug discovery and development activities

Restrain

• High cost associated with initial setup and maintenance

Opportunity

• The growing number of Contract Research Organizations (CROs) providing HCS services

Market Players

Some of the major market players operating in the North America high content screening market are:

• BD
• Merck KGaA
• Corning Incorporated
• Carl Zeiss AG
• Sartorius AG
• EVIDENT
• Zifo RnD Solutions
• Molecular Devices, LLC. (Subsidiary of Danaher Corporation)
• Thermo Fisher Scientific Inc.
• PerkinElmer Inc.
• Bio-Rad Laboratories, Inc.
• Agilent Technologies, Inc.
• Yokogawa Electric Corporation
• Sysmex Corporation
• Genedata AG
• De Novo Software
• Araceli Biosciences
• Miltenyi Biotec
• Aligned Genetics, Inc.

1 Introduction: 1.1 Objectives Of The Study; 1.2 Market Definition; 1.3 Overview Of The North America High Content Screening Market; 1.4 Limitations; 1.5 Markets Covered
2 Market Segmentation: 2.1 Markets Covered; 2.2 Geographical Scope; 2.3 Years Considered For The Study; 2.4 Currency And Pricing; 2.5 Dbmr Tripod Data Validation Model; 2.6 Multivariate Modelling; 2.7 Product Type Lifeline Curve; 2.8 Primary Interviews With Key Opinion Leaders; 2.9 Dbmr Market Position Grid; 2.10 Market Application Coverage Grid; 2.11 Vendor Share Analysis; 2.12 Secondary Sources; 2.13 Assumptions
3 Executive Summary
4 Premium Insights: 4.1 Pestel Analysis; 4.2 Porter's Five Forces Model
5 North America High Content Screening Market: Regulations
6 Market Overview, North America High Content Screening Market: 6.1 Drivers; 6.1.1 Advancement In Imaging Technologies Used For High Content Screening; 6.1.2 Strategic Initiatives Taken By Market Players; 6.1.3 Increasing Research Activities Associated With The Usage Of High Content Screening; 6.1.4 Increasing Drug Discovery And Development Activities; 6.2 Restraints; 6.2.1 High Cost Associated With Initial Setup And Maintenance; 6.2.2 Complexity Associated With Cellular And Molecular Samples; 6.3 Opportunities; 6.3.1 Growing Number Of Contract Research Organizations (Cros) Providing Hcs Services; 6.3.2 Rising Integration With Artificial Intelligence And Machine Learning In Drug Discovery And Development; 6.3.3 Increasing Government Initiative And Funding In R&D; 6.4 Challenges; 6.4.1 Lack Of Skilled And Certified Professionals To Operate Hcs; 6.4.2 Data Security And Data Management Problems In Hcs
7 North America High Content Screening Market, By Product Type: 7.1 Overview; 7.2 Instruments; 7.2.1 Cell Imaging And Analysis System; 7.2.1.1 Fixed; 7.2.1.2 Mobile; 7.2.2 High-content And Screening System; 7.2.2.1 Fixed; 7.2.2.2 Mobile; 7.2.3 Flow Cytometry; 7.2.4 Invitrogen Hca Onstage Incubator; 7.2.5 Microplate Mover; 7.2.6 Others; 7.3 Software; 7.4 Consumables; 7.4.1 Reagents & Assay Kits; 7.4.2 Microplates; 7.4.3 Others; 7.5 Accessories; 7.6 Services
8 North America High Content Screening Market, By Application: 8.1 Overview; 8.2 Primary And Secondary Screening; 8.2.1 Instruments; 8.2.2 Consumables; 8.2.3 Accessories; 8.2.4 Services; 8.3 Target Identification And Validation; 8.3.1 Instruments; 8.3.2 Consumables; 8.3.3 Accessories; 8.3.4 Services; 8.4 Toxicity Studies; 8.4.1 Instruments; 8.4.2 Consumables; 8.4.3 Accessories; 8.4.4 Services; 8.5 Compound Profiling; 8.5.1 Instruments; 8.5.2 Consumables; 8.5.3 Accessories; 8.5.4 Services; 8.6 Other Applications
9 North America High Content Screening Market, By Technology: 9.1 Overview; 9.2 Microscopy; 9.3 Flow Cytometry; 9.4 Immunohistochemistry; 9.5 Mass Spectrometry; 9.6 Elisa; 9.7 Western Blotting; 9.8 Others; 9.8.1 3d Cell Culture Model; 9.8.1.1 Steroids; 9.8.1.2 Organoids; 9.8.1.3 Tissue On A Chip; 9.8.2 Extracellular Matrix Based Scaffold; 9.8.3 Synthetic Hydrogel And Scaffold
10 North America High Content Screening Market, By End User: 10.1 Overview; 10.2 Pharmaceutical And Biotechnology Companies; 10.2.1 Instruments; 10.2.2 Consumables; 10.2.3 Accessories; 10.2.4 Services; 10.3 Contract Research Organizations; 10.3.1 Instruments; 10.3.2 Consumables; 10.3.3 Accessories; 10.3.4 Services; 10.4 Laboratories; 10.4.1 Instruments; 10.4.2 Consumables; 10.4.3 Accessories; 10.4.4 Services; 10.5 Academic And Government Institutes; 10.5.1 Instruments; 10.5.2 Consumables; 10.5.3 Accessories; 10.5.4 Services; 10.6 Others
11 North America High Content Screening Market, By Distribution Channel: 11.1 Overview; 11.2 Direct Tenders; 11.3 Retail Sales
12 North America High Content Screening Market, By Region: 12.1 North America; 12.1.1 U.S.; 12.1.2 Canada; 12.1.3 Mexico
13 North America High Content Screening Market, Company Landscape: 13.1 Company Share Analysis: North America
14 North America Content Screening Market, Company Profiles: 14.1 Thermo Fisher Scientific Inc. (2022); 14.1.1 Company Snapshot; 14.1.2 Revenue Analysis; 14.1.3 Company Share Analysis; 14.1.4 Product Portfolio; 14.1.5 Recent Development; 14.2 Bd; 14.2.1 Company Snapshot; 14.2.2 Revenue Analysis; 14.2.3 Company Share Analysis; 14.2.4 Product Portfolio; 14.2.5 Recent Developments; 14.3 Perkinelmer Inc. (2022); 14.3.1 Company Snapshot; 14.3.2 Revenue Analysis; 14.3.3 Company Share Analysis; 14.3.4 Product Portfolio; 14.3.5 Recent Developments; 14.4 Yokogawa Electric Corporation (2022); 14.4.1 Company Snapshot; 14.4.2 Revenue Analysis; 14.4.3 Company Share Analysis; 14.4.4 Product Portfolio; 14.4.5 Recent Development; 14.5 Molecular Devices, Llc. (A Subsidiary Of Danaher Corporation); 14.5.1 Company Snapshot; 14.5.2 Revenue Analysis; 14.5.3 Company Share Analysis; 14.5.4 Product Portfolio; 14.5.5 Recent Development; 14.6 Agilent Technologies, Inc. (2022); 14.6.1 Company Snapshot; 14.6.2 Revenue Analysis; 14.6.3 Product Portfolio; 14.6.4 Recent Development; 14.7 Aligned Genetics, Inc. (2022); 14.7.1 Company Snapshot; 14.7.2 Revenue Analysis; 14.7.3 Product Portfolio; 14.7.4 Recent Development; 14.8 Araceli Biosciences; 14.8.1 Company Snapshot; 14.8.2 Product Portfolio; 14.8.3 Recent Development; 14.9 Axxam S.P.A; 14.9.1 Company Snapshot; 14.9.2 Product Portfolio; 14.9.3 Recent Development; 14.10 Bio-rad Laboratories, Inc. (2022); 14.10.1 Company Snapshot; 14.10.2 Revenue Analysis; 14.10.3 Product Portfolio; 14.10.4 Recent Developments; 14.11 Carl Zeiss Ag; 14.11.1 Company Snapshot; 14.11.2 Revenue Analysis; 14.11.3 Product Portfolio; 14.11.4 Recent Development; 14.12 Corning Incorporated; 14.12.1 Company Snapshot; 14.12.2 Revenue Analysis; 14.12.3 Product Portfolio; 14.12.4 Recent Development; 14.13 De Novo Software; 14.13.1 Company Snapshot; 14.13.2 Product Portfolio; 14.13.3 Recent Developments; 14.14 Evident; 14.14.1 Company Snapshot; 14.14.2 Product Portfolio; 14.14.3 Recent Development; 14.15 Genedata Ag; 14.15.1 Company Snapshot; 14.15.2 Product Portfolio; 14.15.3 Recent Development; 14.16 Merck Kgaa; 14.16.1 Company Snapshot; 14.16.2 Revenue Analysis; 14.16.3 Product Portfolio; 14.16.4 Recent Developments; 14.17 Miltenyi Biotec; 14.17.1 Company Snapshot; 14.17.2 Product Portfolio; 14.17.3 Recent Development; 14.18 Sartorius Ag; 14.18.1 Company Snapshot; 14.18.2 Revenue Analysis; 14.18.3 Product Portfolio; 14.18.4 Recent Developments; 14.19 Sysmex Corporation; 14.19.1 Company Snapshot; 14.19.2 Revenue Analysis; 14.19.3 Product Portfolio; 14.19.4 Recent Development; 14.20 Zifo Rnd Solutions; 14.20.1 Company Snapshot; 14.20.2 Product Portfolio; 14.20.3 Recent Developments
15 Questionnaire
16 Related Reports
List Of Tables: Table 1 North America High Content Screening Market, By Product Type, 2021-2030 (Usd Thousand); Table 2 North America Instruments In High Content Screening Market, By Region, 2021-2030 (Usd Thousand); Table 3 North America Instruments In High Content Screening Market, By Product Type, 2021-2030 (Usd Thousand); Table 4 North America Cell Imaging And Analysis System In High Content Screening Market, By Product Type, 2021-2030 (Usd Thousand); Table 5 North America High-content And Screening System In High Content Screening Market, By Product Type, 2021-2030 (Usd Thousand); Table 6 North America Softwares In High Content Screening Market, By Region, 2021-2030 (Usd Thousand); Table 7 North America Consumables In High Content Screening Market, By Region, 2021-2030 (Usd Thousand); Table 8 North America Consumables In High Content Screening Market, By Product Type, 2021-2030 (Usd Thousand); Table 9 North America Accessories In High Content Screening Market, By Region, 2021-2030 (Usd Thousand); Table 10 North America Services In High Content Screening Market, By Region, 2021-2030 (Usd Thousand); Table 11 North America High Content Screening Market, By Application, 2021-2030 (Usd Thousand); Table 12 North America Primary And Secondary Screening In High Content Screening Market, By Region, 2021-2030 (Usd Thousand); Table 13 North America Primary And Secondary Screening In High Content Screening Market, By Product Type, 2021-2030 (Usd Thousand); Table 14 North America Target Identification & Validation In High Content Screening Market, By Region, 2021-2030 (Usd Thousand); Table 15 North America Target Identification & Validation In High Content Screening Market, By Product Type, 2021-2030 (Usd Thousand); Table 16 North America Toxicity Studies In High Content Screening Market, By Region, 2021-2030 (Usd Thousand); Table 17 North America Toxicity Studies In High Content Screening Market, By Product Type, 2021-2030 (Usd Thousand); Table 18 North America Compound Profiling In High Content Screening Market, By Region, 2021-2030 (Usd Thousand); Table 19 North America Compound Profiling In High Content Screening Market, By Product Type, 2021-2030 (Usd Thousand); Table 20 North America Other Application In High Content Screening Market, By Region, 2021-2030 (Usd Thousand); Table 21 North America High Content Screening Market, By Technology, 2021-2030 (Usd Thousand); Table 22 North America Microscopy In High Content Screening Market, By Region, 2021-2030 (Usd Thousand); Table 23 North America Flow Cytometry In High Content Screening Market, By Region, 2021-2030 (Usd Thousand); Table 24 North America Immunohistochemistry In High Content Screening Market, By Region, 2021-2030 (Usd Thousand); Table 25 North America Mass Spectroscopy In High Content Screening Market, By Region, 2021-2030 (Usd Thousand); Table 26 North America Elisa In High Content Screening Market, By Region, 2021-2030 (Usd Thousand); Table 27 North America Western Blotting In High Content Screening Market, By Region, 2021-2030 (Usd Thousand); Table 28 North America Others In High Content Screening Market, By Region, 2021-2030 (Usd Thousand); Table 29 North America Others In High Content Screening Market, By Technology, 2021-2030 (Usd Thousand); Table 30 North America 3d Cell Culture Model In High Content Screening Market, By Technology, 2021-2030 (Usd Thousand); Table 31 North America High Content Screening Market, By End User, 2021-2030 (Usd Thousand); Table 32 North America Pharmaceutical And Biotechnology Companies In High Content Screening Market, By Region, 2021-2030 (Usd Thousand); Table 33 North America Pharmaceutical And Biotechnology Companies In High Content Screening Market, By Product Type, 2021-2030 (Usd Thousand); Table 34 North America Contract Research Organizations In High Content Screening Market, By Region, 2021-2030 (Usd Thousand); Table 35 North America Contract Research Organizations In High Content Screening Market, By Product Type, 2021-2030 (Usd Thousand); Table 36 North America Laboratories In High Content Screening Market, By Region, 2021-2030 (Usd Thousand); Table 37 North America Laboratories In High Content Screening Market, By Product Type, 2021-2030 (Usd Thousand); Table 38 North America Academic And Government Institutes In High Content Screening Market, By Region, 2021-2030 (Usd Thousand); Table 39 North America Academic And Government Institutes In High Content Screening Market, By Product Type, 2021-2030 (Usd Thousand); Table 40 North America Others In High Content Screening Market, By Region, 2021-2030 (Usd Thousand); Table 41 North America High Content Screening Market, By Distribution Channel, 2021-2030 (Usd Thousand); Table 42 North America Direct Tenders In High Content Screening Market, By Region, 2021-2030 (Usd Thousand); Table 43 North America Retail Sales In High Content Screening Market, By Region, 2021-2030 (Usd Thousand); Table 44 North America High Content Screening Market, By Country, 2021-2030 (Usd Thousand); Table 45 North America High Content Screening Market, By Product Type, 2021-2030 (Usd Thousand); Table 46 North America Instruments In High Content Screening Market, By Product Type, 2021-2030 (Usd Thousand); Table 47 North America Cell Imaging And Analysis System In High Content Screening Market, By Product Type, 2021-2030 (Usd Thousand); Table 48 North America High-content Screening System In High Content Screening Market, By Product Type, 2021-2030 (Usd Thousand); Table 49 North America Consumables In High Content Screening Market, By Product Type, 2021-2030 (Usd Thousand); Table 50 North America High Content Screening Market, By Application, 2021-2030 (Usd Thousand); Table 51 North America Primary And Secondary Screening In High Content Screening Market, By Product Type, 2021-2030 (Usd Thousand); Table 52 North America Target Identification & Validation In High Content Screening Market, By Product Type, 2021-2030 (Usd Thousand); Table 53 North America Toxicity Studies In High Content Screening Market, By Product Type, 2021-2030 (Usd Thousand); Table 54 North America Compound Profiling In High Content Screening Market, By Product Type, 2021-2030 (Usd Thousand); Table 55 North America High Content Screening Market, By Technology, 2021-2030 (Usd Thousand); Table 56 North America Others In High Content Screening Market, By Technology, 2021-2030 (Usd Thousand); Table 57 North America 3d Cell Culture Model In High Content Screening Market, By Technology, 2021-2030 (Usd Thousand); Table 58 North America High Content Screening Market, By End User, 2021-2030 (Usd Thousand); Table 59 North America Pharmaceutical And Biotechnology Companies In High Content Screening Market, By Product Type, 2021-2030 (Usd Thousand); Table 60 North America Contract Research Organizations In High Content Screening Market, By Product Type, 2021-2030 (Usd Thousand); Table 61 North America Laboratories In High Content Screening Market, By Product Type, 2021-2030 (Usd Thousand); Table 62 North America Academic And Government Institutes In High Content Screening Market, By Product Type, 2021-2030 (Usd Thousand); Table 63 North America High Content Screening Market, By Distribution Channel, 2021-2030 (Usd Thousand); Table 64 U.S. High Content Screening Market, By Product Type, 2021-2030 (Usd Thousand); Table 65 U.S. Instruments In High Content Screening Market, By Product Type, 2021-2030 (Usd Thousand); Table 66 U.S. Cell Imaging And Analysis System In High Content Screening Market, By Product Type, 2021-2030 (Usd Thousand); Table 67 U.S. High-content Screening System In High Content Screening Market, By Product Type, 2021-2030 (Usd Thousand); Table 68 U.S. Consumables In High Content Screening Market, By Product Type, 2021-2030 (Usd Thousand); Table 69 U.S. High Content Screening Market, By Application, 2021-2030 (Usd Thousand); Table 70 U.S. Primary And Secondary Screening In High Content Screening Market, By Product Type, 2021-2030 (Usd Thousand); Table 71 U.S. Target Identification & Validation In High Content Screening Market, By Product Type, 2021-2030 (Usd Thousand); Table 72 U.S. Toxicity Studies In High Content Screening Market, By Product Type, 2021-2030 (Usd Thousand); Table 73 U.S. Compound Profiling In High Content Screening Market, By Product Type, 2021-2030 (Usd Thousand); Table 74 U.S. High Content Screening Market, By Technology, 2021-2030 (Usd Thousand); Table 75 U.S. Others In High Content Screening Market, By Technology, 2021-2030 (Usd Thousand); Table 76 U.S. 3d Cell Culture Model In High Content Screening Market, By Technology, 2021-2030 (Usd Thousand); Table 77 U.S. High Content Screening Market, By End User, 2021-2030 (Usd Thousand); Table 78 U.S. Pharmaceutical And Biotechnology Companies In High Content Screening Market, By Product Type, 2021-2030 (Usd Thousand); Table 79 U.S. Contract Research Organizations In High Content Screening Market, By Product Type, 2021-2030 (Usd Thousand); Table 80 U.S. Laboratories In High Content Screening Market, By Product Type, 2021-2030 (Usd Thousand); Table 81 U.S. Academic And Government Institutes In High Content Screening Market, By Product Type, 2021-2030 (Usd Thousand); Table 82 U.S. High Content Screening Market, By Distribution Channel, 2021-2030 (Usd Thousand); Table 83 Canada High Content Screening Market, By Product Type, 2021-2030 (Usd Thousand); Table 84 Canada Instruments In High Content Screening Market, By Product Type, 2021-2030 (Usd Thousand); Table 85 Canada Cell Imaging And Analysis System In High Content Screening Market, By Product Type, 2021-2030 (Usd Thousand); Table 86 Canada High-content Screening System In High Content Screening Market, By Product Type, 2021-2030 (Usd Thousand); Table 87 Canada Consumables In High Content Screening Market, By Product Type, 2021-2030 (Usd Thousand); Table 88 Canada High Content Screening Market, By Application, 2021-2030 (Usd Thousand); Table 89 Canada Primary And Secondary Screening In High Content Screening Market, By Product Type, 2021-2030 (Usd Thousand); Table 90 Canada Target Identification & Validation In High Content Screening Market, By Product Type, 2021-2030 (Usd Thousand); Table 91 Canada Toxicity Studies In High Content Screening Market, By Product Type, 2021-2030 (Usd Thousand); Table 92 Canada Compound Profiling In High Content Screening Market, By Product Type, 2021-2030 (Usd Thousand); Table 93 Canada High Content Screening Market, By Technology, 2021-2030 (Usd Thousand); Table 94 Canada Others In High Content Screening Market, By Technology, 2021-2030 (Usd Thousand); Table 95 Canada 3d Cell Culture Model In High Content Screening Market, By Technology, 2021-2030 (Usd Thousand); Table 96 Canada High Content Screening Market, By End User, 2021-2030 (Usd Thousand); Table 97 Canada Pharmaceutical And Biotechnology Companies In High Content Screening Market, By Product Type, 2021-2030 (Usd Thousand); Table 98 Canada Contract Research Organizations In High Content Screening Market, By Product Type, 2021-2030 (Usd Thousand); Table 99 Canada Laboratories In High Content Screening Market, By Product Type, 2021-2030 (Usd Thousand); Table 100 Canada Academic And Government Institutes In High Content Screening Market, By Product Type, 2021-2030 (Usd Thousand); Table 101 Canada High Content Screening Market, By Distribution Channel, 2021-2030 (Usd Thousand); Table 102 Mexico High Content Screening Market, By Product Type, 2021-2030 (Usd Thousand); Table 103 Mexico Instruments In High Content Screening Market, By Product Type, 2021-2030 (Usd Thousand); Table 104 Mexico Cell Imaging And Analysis System In High Content Screening Market, By Product Type, 2021-2030 (Usd Thousand); Table 105 Mexico High-content Screening System In High Content Screening Market, By Product Type, 2021-2030 (Usd Thousand); Table 106 Mexico Consumables In High Content Screening Market, By Product Type, 2021-2030 (Usd Thousand); Table 107 Mexico High Content Screening Market, By Application, 2021-2030 (Usd Thousand); Table 108 Mexico Primary And Secondary Screening In High Content Screening Market, By Product Type, 2021-2030 (Usd Thousand); Table 109 Mexico Target Identification & Validation In High Content Screening Market, By Product Type, 2021-2030 (Usd Thousand); Table 110 Mexico Toxicity Studies In High Content Screening Market, By Product Type, 2021-2030 (Usd Thousand); Table 111 Mexico Compound Profiling In High Content Screening Market, By Product Type, 2021-2030 (Usd Thousand); Table 112 Mexico High Content Screening Market, By Technology, 2021-2030 (Usd Thousand); Table 113 Mexico Others In High Content Screening Market, By Technology, 2021-2030 (Usd Thousand); Table 114 Mexico Pharmaceutical And Biotechnology Companies In High Content Screening Market, By Product Type, 2021-2030 (Usd Thousand); Table 115 Mexico Contract Research Organizations In High Content Screening Market, By Product Type, 2021-2030 (Usd Thousand); Table 116 Mexico Laboratories In High Content Screening Market, By Product Type, 2021-2030 (Usd Thousand); Table 117 Mexico Academic And Government Institutes In High Content Screening Market, By Product Type, 2021-2030 (Usd Thousand); Table 118 Mexico High Content Screening Market, By Distribution Channel, 2021-2030 (Usd Thousand)
List Of Figures: Figure 1 North America High Content Screening Market: Segmentation; Figure 2 North America High Content Screening Market: Data Triangulation; Figure 3 North America High Content Screening Market: Droc Analysis; Figure 4 North America High Content Screening Market: North America Vs Regional Market Analysis; Figure 5 North America High Content Screening Market: Company Research Analysis; Figure 6 North America High Content Screening Market: Interview Demographics; Figure 7 North America High Content Screening Market: Dbmr Market Position Grid; Figure 8 North America High Content Screening Market: Market Application Coverage Grid; Figure 9 North America High Content Screening Market: Vendor Share Analysis; Figure 10 North America High Content Screening Market: Segmentation; Figure 11 Advancement In Imaging Technologies Used For High-content Screening Is Expected To Drive The Growth Of The North America High Content Screening Market In The Forecast Period; Figure 12 The Product Type Segment Is Expected To Account For The Largest Share Of The North America High Content Screening Market In 2023 And 2030; Figure 13 Drivers, Restraints, Opportunities, And Challenges Of The North America High Content Screening Market; Figure 14 North America High Content Screening Market: By Product Type, 2022; Figure 15 North America High Content Screening Market: By Product Type, 2023-2030 (Usd Thousand); Figure 16 North America High Content Screening Market: By Product Type, Cagr (2023-2030); Figure 17 North America High Content Screening Market: By Product Type, Lifeline Curve; Figure 18 North America High Content Screening Market: By Application, 2022; Figure 19 North America High Content Screening Market: By Application, 2023-2030 (Usd Thousand); Figure 20 North America High Content Screening Market: By Application, Cagr (2023-2030); Figure 21 North America High Content Screening Market: By Application, Lifeline Curve; Figure 22 North America High Content Screening Market: By Technology, 2022; Figure 23 North America High Content Screening Market: By Technology, 2023-2030 (Usd Thousand); Figure 24 North America High Content Screening Market: By Technology, Cagr (2023-2030); Figure 25 North America High Content Screening Market: By Technology, Lifeline Curve; Figure 26 North America High Content Screening Market: By End User, 2022; Figure 27 North America High Content Screening Market: By End User, 2023-2030 (Usd Thousand); Figure 28 North America High Content Screening Market: By End User, Cagr (2023-2030); Figure 29 North America High Content Screening Market: By End User, Lifeline Curve; Figure 30 North America High Content Screening Market: By Distribution Channel, 2022; Figure 31 North America High Content Screening Market: By Distribution Channel, 2023-2030 (Usd Thousand); Figure 32 North America High Content Screening Market: By Distribution Channel, Cagr (2023-2030); Figure 33 North America High Content Screening Market: By Distribution Channel, Lifeline Curve; Figure 34 North America High Content Screening Market: Snapshot (2022); Figure 35 North America High Content Screening Market: By Country (2022); Figure 36 North America High Content Screening Market: By Country (2023 & 2030); Figure 37 North America High Content Screening Market: By Country (2022 & 2030); Figure 38 North America High Content Screening Market: By Product Type (2023-2030); Figure 39 North America High Content Screening Market: Company Share 2022 (%) 135